Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Roche seeks European approval for novel anemia drug CERA

April 27, 2006

European approval for Preotact

April 27, 2006

Target enrollment completed in phase IIa study of E1-I.N.T. for type 2 diabetes

April 27, 2006

PhytoMedical to focus on development of specific polyphenols

April 27, 2006

FAST I phase III trial of icatibant for HAE completes randomization

April 26, 2006

Humatrope approved for growth hormone deficiency in Japan

April 25, 2006

New trial studies WinRho SDF in HCV patients

April 25, 2006

Novel treatment options for endocrine-related disorders disclosed in recent patents

April 24, 2006

Takeda and Lilly conclude U.S. Actos marketing collaboration

April 24, 2006

Yaz now available

April 24, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...